(Q36772957)

English

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients

scientific article published on 9 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Adriana Zeevi

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

John Lunz

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Brian Feingold

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Michael Shullo

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Christian Bermudez

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jeffery Teuteberg

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Steven Webber

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

publication date

9 November 2012

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

The Journal of Heart and Lung Transplantation

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

32

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

98-105

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

The use of the calculated panel-reactive antibody and virtual crossmatch in heart transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

29 September 2017

The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

29 September 2017

Using real data for a virtual crossmatch

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

29 September 2017

Report from a consensus conference on the sensitized patient awaiting heart transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

29 September 2017

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

29 September 2017

HLA antibody specification using single-antigen beads--a technical solution for the prozone effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Calculated PRA: initial results show benefits for sensitized patients and a reduction in positive crossmatches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3628631

5 September 2018

Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches

1 reference

https://pubmed.ncbi.nlm.nih.gov/23142561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient

1 reference

https://pubmed.ncbi.nlm.nih.gov/23142561

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.HEALUN.2012.09.021

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36772957&oldid=1515945273"